Deseret Mutual Benefit Administrators Purchases 61 Shares of Humana Inc. (NYSE:HUM)

Deseret Mutual Benefit Administrators lifted its position in Humana Inc. (NYSE:HUM) by 18.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 399 shares of the insurance provider’s stock after buying an additional 61 shares during the period. Deseret Mutual Benefit Administrators’ holdings in Humana were worth $101,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. Camelot Portfolios LLC bought a new stake in shares of Humana in the 4th quarter valued at $574,000. Peregrine Asset Advisers Inc. bought a new position in Humana during the 4th quarter worth about $4,327,000. Transcend Capital Advisors LLC increased its holdings in Humana by 399.7% during the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock worth $924,000 after purchasing an additional 2,914 shares in the last quarter. Paradigm Asset Management Co. LLC increased its holdings in Humana by 766.7% during the 4th quarter. Paradigm Asset Management Co. LLC now owns 2,600 shares of the insurance provider’s stock worth $660,000 after purchasing an additional 2,300 shares in the last quarter. Finally, Centricity Wealth Management LLC bought a new position in Humana during the 4th quarter worth about $30,000. Institutional investors own 92.38% of the company’s stock.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the firm’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 0.32% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on HUM. Truist Financial increased their target price on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Piper Sandler increased their target price on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Barclays increased their target price on Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday, February 13th. Wells Fargo & Company lowered their target price on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Finally, JPMorgan Chase & Co. decreased their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday, February 18th. Nineteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $285.68.

Humana Trading Down 5.7 %

Shares of NYSE:HUM opened at $255.77 on Friday. The company has a 50-day simple moving average of $269.41 and a 200 day simple moving average of $290.00. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market capitalization of $30.80 billion, a P/E ratio of 25.71, a price-to-earnings-growth ratio of 2.05 and a beta of 0.56. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46.

Humana (NYSE:HUM) last issued its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.38%. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.